Blue Horseshoe Stocks

BMSN, AMBS, AAPL & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN

BMSN has been like a rocket lately, blasting off since we first alerted the stock back on December 26th.We have seen five consecutive days of gains, with Monday’s action breaking a previous resistance point of .0021 and reaching a high of ,0024, before closing at .0016.Considering the momentum we witnessed over the past five sessions, we are expecting to see a pullback at some point. In such an event, we’d like to see the support hold off of the 50DMA of .001.

Our next key level of resistance is going to be at .0024. If it can get past that, the next level is .003, and .004 (200DMA).

___

Amarantus Bioscience, Inc. AMBS

We first began talking about AMBS on November 6th. Another one on a serious uptrend; in the past 14 days of trading, the stock has seen just two days of closing in the red.

AMBS will be co-hosting an international symposium , the #C4CT Concussion Awareness Conference, “with the purpose of bringing thought leaders in the field of Traumatic Brain Injury (“TBI”) drug and diagnostic research & development, professional athletes, former professional athletes and celebrity sports figureheads that share the Company’s, TCMG’s and Brewer’s desire to support research into new TBI treatments, sports leagues who have social and fiduciary responsibilities to improve player safety and caring for former players previously affected by TBI and cognitive disorders, as well as other key stakeholders in the ongoing social discussion regarding head injuries and their side effects.”

BARCHART.COM currently has AMBS rated a “100% Buy”

We had stated before that we were looking for a break past .13, and that it would bring us into bluesky breakout mode, and now that it has done so, we’re going to hold onto our hats, because there’s no telling where it could stop. We’d like to see .13 hold as the new base level of support.

___

Apple, Inc. AAPL

AAPL was as low as 510.24 on Dec. 21st, and dipping as low as 504.66 on December 27th. With all of the hype coming from “fiscal cliff” negotiations, Monday’s big rally (closed at 532.1729) has the stock trading close to 550.00 premarket today.

___
Extended Watchlist:

MSSD, BTHR, FORC, PPHM, MDIN, CTIX, SNTL, DNYS, KWK, NOK

Blue Horseshoe Stocks 2012 Wrap-Up Report

HAVE A SAFE AND HAPPY NEW YEAR

The short week that is now upon us will mark the beginning of a new year! 2012 was an extremely successful stretch for us, and we are anxious to make 2013 even better. A tall order, but one that we will gladly attempt to fill, and we hope you will stay with us every step of the way! Before we jump into today’s report, lets have a look at our Top 5 Winning Picks from 2012.

ATRN Range: .0148-.3599 Gained: 2332%
BBDA Range: .0015-.0199 Gained: 1227%
ANTS Range: .0034-0328 Gained: 865%
MWIP Range: .0024-.0199 Gained: 729%
AMBS Range: .017-.1295 Gained: 662%

Let us also not forget our series of medical marijuana round-up reports that we began publishing on October 16th. The following weeks brought us cumulative gains on the order of 885% from stocks contained in those reports. We had success across the board this year, including swathes of other percentage gains, the total of which surely numbers in the tens-of-thousands.

Like we said, the wins will continue to pile up in 2013, and based on how things have been going, we anticipate this will be our best year ever. You most assuredly don’t want to miss it. The wildly successful “Extended Watchlist” portion of our daily reports that we implemented this year will continue to be a staple moving forward, and as always we are open to correspondence/suggestions from our reader-base.

___

Extended Watchlist:

BMSN, IVAN, LXRX, HLNT, PPHM, DNYS, SNTL, LTSN

BMSN, DNYS & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN

BMSN has appeared on our watchlist for the past couple of days, starting the day after Christmas, during which time the stock traded in a range from Wednesday’s low of .0003 all the way up to yesterday’s high of .0013 for a titanic two-session gain of 333%

___

Dynasty Limousine, Inc. DNYS

DNYS was added to our extended watchlist for the first time yesterday, after we saw the stock come off of its bottom last week.

The stock opened at .078, closing at the high of day of .1194. A break past the 50DMA of .12 would catapult DNYS to even more impressive gains, so this is definitely one to watch into the New Year. The stock has seen a surge into the mid-.40’s as recently as November, so we are aware of the gains it is capable of producing.

The chart is looking extremely favorable, with the PPS having broken through the 20, 100 & 200DMA’s, and the RSI looking like it wants to break through the 50DMA soon. The PPO is pinching in for a cross, as well as the histogram looking ready to flip up to the bullish side. The Slow STO recently crossed over, and is diverging as it prepares to cross the 50DMA.

____

Extended Watchlist:
PEIX, BIOF, AEZS, GALE, CTIX, HLNT,

AMBS & Extended Watchlist

Amarantus Biosciences, Inc. AMBS

AMBS went on to hit a new high of day after our afternoon update yesterday, touching .1129. From a recent low of .017, that marks a whopping gain of 564%The stock turned in quite an impressive dollar volume (Over $3M), the biggest trading session since the first day we started tracking it on Nov. 6th.

The next key area of resistance to break will be .13; if it can’t push through that point, we will be expecting a pullback, however any move past the .13-mark will result in a bluesky breakout.

____

Extended Watchlist:
SWRF, PCFG, BMSN, DNYS, APWR

Wednesday Afternoon Updates

Abby, Inc. ABBY

This morning, ABBY opened up at .155 as trades were going off at the offer. Following a wave of selling pressure, we unfortunately lost our key level of support, and are now monitoring for a new level of support.

We will watch closely for the selling pressure to ease off, and for the bid to solidify. This morning’s activity does not change ABBY’s status as a bottom-play trading near all-time lows. Our experience with bottom-plays in the past tells us that we need to be patient, and ready for any stir that can turn into the next big run.

Sell-offs can often cause people undue worry, so let’s not forget the exciting happenings with ABBY’s Nebraska oil field projects as outlined in this morning’s report. Any word of progress in that regard could be just the catalyst we are looking for to jumpstart ABBY off of its bottom.

____

Amarantus Biosciences, Inc. AMBS

We have been talking about AMBS since November 6th. Since that time, the stock has seen a low of .017 (Dec. 3rd), and a subsequent high of .0945 today. That move marks a gain of 456%____

Southridge Enterprises, Inc. SRGE

SRGE has been a topic of discussion for us since September 6th. In that span of nearly three months, we’ve seen the stock trade in a range from .001 (Sept. 17) on up to .0194 (Nov. 26th) for a monster 1840% move. It then dipped back to .0045 before running to .015 for an added 233% rip.

With the type of news we saw out of SRGE today, we wouldnt be surprised to see it retest previous highs:

DALLAS, Dec. 26, 2012 /PRNewswire via COMTEX/ — Southridge Enterprises Inc. (PINKSHEETS: SRGE) (“Southridge” or the “Company”) is excited to announce a new Joint Partner, Kinross (NYSE: KGC), a Major listed Mining Company for its Cinco Minas and Gran Cabrera properties. Southridge’s joint partnership with Kinross, a major NYSE listed gold mining company, is valued at roughly $550,000,000 to $600,000,000. Due to numerous shareholder inquiries Southridge and its Board of Directors felt the need to update the market on its recent announcement named, “Southridge Announces Signed Agreement with Major NYSE Listed Mining Company on Cinco Minas and Gran Cabrera Gold & Silver Mines in Mexico.”

Southridge and its advisers are currently working hand in hand with Kinross to finalize the remaining documents and agreements in order to execute this new joint partnership for its Cinco Minas and Gran Cabrera properties with Kinross. Due to the size and complexity of this transaction we expect to execute this joint partnership with Kinross by Mid-January.
____

Extended Watchlist:
CTIX, EPGL,PAYD, BMSN